BMC Cancer

official impact factor 3.15
Search for
Advanced search
BMC Cancer
Tools
Open Access Highly Access

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers

Loukas F Kontovinis, Konstantinos T Papazisis*, Panagiota Touplikioti, Charalambos Andreadis, Despoina Mouratidou and Alexandros H Kortsaris

BMC Cancer 2009, 9:82 doi:10.1186/1471-2407-9-82

Accesses  

  • Last 30 days: 54 accesses
  • Last year: 660 accesses
  • All time: 3577 accesses

Cited by

BioMed Central: 1 citation

Research article   Open Access Highly Accessed

Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma

Naomi Walsh, Annemarie Larkin, Susan Kennedy, Lisa Connolly, Jo Ballot, Wei Ooi, Giuseppe Gullo, John Crown, Martin Clynes, Lorraine O'Driscoll BMC Urology 2009, 9:6 (24 June 2009)

Abstract | Full text | PDF | PubMed

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations